PARADIGM OlaPArib And RADiotherapy In newly-diagnosed GlioblastoMa:

Trial description
Short-course radiotherapy plus olaparib for newly diagnosed glioblastoma in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose escalation study
Contact name
Dr Sarah Jefferies
Trial start date
Friday, November 4, 2016
Trial end date
Sunday, August 19, 2018
Trial tumour type
Brain and CNS
Show on Radiotherapy